GLP News

Novo Nordisk Names Maziar Mike Doustdar CEO as Shares Plunge 25% on Wegovy Sales Outlook Cut; US Medicare, Medicaid to Pilot GLP-1 Drug Coverage

4 days ago

Trump Administration to Pilot Medicare and Medicaid Coverage for Weight-Loss Drugs Starting 2026; Eli Lilly, Novo Nordisk Shares Rise Amid Market Shift

1 day ago

[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...

Nov 18, 10:14 PMJan 1, 4:59 AM

204365

OptionProbability

2030

2029

2028

2026

2027

2025

Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?

Oct 8, 10:12 PMOct 16, 5:59 AM

14.56%chance

83695

OptionVotes

YES

2422

413

Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025

Jul 2, 7:40 AMJan 1, 4:59 AM

6.87%chance

213474

OptionVotes

YES

3699

434

By 2030, will LLMs have a bigger impact on the economy than GLP-1 receptor agents?

Oct 3, 12:05 PMJan 2, 4:59 AM

85.19%chance

582894

OptionVotes

YES

974

943

Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027

Apr 29, 12:40 PMJan 1, 6:59 AM

81.45%chance

332254

OptionVotes

YES

1725

697

Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss

Feb 7, 1:31 AMJan 1, 7:59 AM

65.43%chance

271378

OptionVotes

YES

1246

789

Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?

Mar 8, 4:50 PMDec 31, 10:59 PM

30%chance

251266

OptionVotes

YES

1194

845

Clinical trial shows by 2030 that GLP-1 receptor agonists significantly reduce osteoarthritis symptoms

Jun 26, 2:19 AMDec 31, 11:59 PM

67.73%chance

3537

OptionVotes

YES

1449

690

By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?

Jan 20, 9:19 AMDec 31, 10:59 PM

85.51%chance

3204

OptionVotes

YES

1096

949

Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025

Aug 20, 2:29 AMFeb 1, 4:59 AM

41.86%chance

8173

OptionVotes

YES

268

Will a majority government owned company introduce a new GLP-1 drug before 2040?

Jan 25, 9:23 PMDec 31, 10:59 PM

15.33%chance

1135

OptionVotes

YES

235

Joel Habener wins the Nobel Prize in Physiology or Medicine before 2030 for isolating and characterizing GLP-1

Apr 11, 10:52 AMDec 31, 11:59 PM

51.13%chance

7104

OptionVotes

YES

102

Latest stories

Aug 3, 2025
Aug 3, 2025
Stocks
Pharma
Politics
Trump Administration to Pilot Medicare and Medicaid Coverage for Weight-Loss Drugs Starting 2026; Eli Lilly, Novo Nordisk Shares Rise Amid Market Shift
Authors
24
1 day ago
Aug 1, 2025
Aug 1, 2025
US Domestic Policy
Company Earnings
Pharma
Novo Nordisk Names Maziar Mike Doustdar CEO as Shares Plunge 25% on Wegovy Sales Outlook Cut; US Medicare, Medicaid to Pilot GLP-1 Drug Coverage
Authors
30
4 days ago

Join our channels

Get the latest stories live on any device.

WhatsApp
Top Stories
Join
Telegram
Top Stories
Join

GLP News

Top stories

Prediction markets for GLP

Prediction markets for GLP

Prediction markets for GLP

[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...

Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?

Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025

By 2030, will LLMs have a bigger impact on the economy than GLP-1 receptor agents?

Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027

Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss

Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?

Clinical trial shows by 2030 that GLP-1 receptor agonists significantly reduce osteoarthritis symptoms

By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?

Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025

Will a majority government owned company introduce a new GLP-1 drug before 2040?

Joel Habener wins the Nobel Prize in Physiology or Medicine before 2030 for isolating and characterizing GLP-1

Latest stories

Join our channels

WhatsApp

Telegram